Paris Panayiotopoulos

At-a-Glance

Partner and member of the Investment Committee at Blackstone Life Sciences
Founder of Anthos Therapeutics (Sold to Novartis in 2025)
Founder of Avencell
Founder and Chairman of Genevant Sciences
CEO, President, and Board Member of Ariad Pharmaceuticals, Inc. (Sold to Takeda in 2017)
Board Director at The Medicines Company (Sold to Novartis in 2020)

Biography

Paris Panayiotopoulos is a Partner and member of the Investment Committee at Blackstone Life Sciences, where he also serves as a Senior Managing Director. His career includes significant experience in investment and leadership within the life sciences sector.

He has founded several companies, including Anthos Therapeutics, which was sold to Novartis in 2025, Avencell, and Genevant Sciences, where he was also Chairman.